Latest Queen's University Stories
CALGARY, Feb. 18, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
LONDON, ON, June 13, 2014 /CNW/ - KalGene Pharmaceuticals, Inc. (KalGene) is expediting development of a prognostic marker
A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives.
Preeclampsia (PE) is a high blood pressure disorder that occurs during pregnancy and which can cause illness or death for the fetus and mother-to-be.
The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G.
The first ever review of abuse cases related to child death or serious injury in Northern Ireland will be launched at Queen's University today (24 January 2013).
- Emitting flashes of light; glittering.